1. Home
  2. Fourth fodder scam case: Lalu Prasad convicted, Jagannath Mishra acquitted

Fourth fodder scam case: Lalu Prasad convicted, Jagannath Mishra acquitted

Agencies
March 19, 2018

New Delhi, Mar 19: Lalu Prasad was today convicted by the special CBI court in the fourth fodder scamcase relating to alleged withdrawal of Rs 3.13 crore from the Dumka treasury over two decades ago.

However, former Bihar Chief Minister Jagannath Mishra found not guilty in the case. In total, 12 accused have been convicted, while five have been acquitted.

A fifth case relating to alleged fraudulent withdrawal of Rs 139 crore from the Doranda treasury in Ranchi is pending with the court.

Lalu Prasad was admitted to a hospital on Saturday for treatment after he complained of chest pain.

The court had postponed the judgement on Thursday in view of the Lalu Prasad's counsel filing a petition under 319 CrPC asking the then three officials of the Accountant General (in the 1990s) be made a party to the case.

Section 319 Cr PC is invoked when there is some strong and cogent evidence against the accused.

Prasad's counsel said he had filed the petition on March 14 and re-submitted it yesterday after correcting some typographical mistakes.

The special CBI court of Shiv Pal Singh allowed admission of the petition.

After perusal of records, the court found prima facie case and the petition filed on March 14 was allowed.

Apart from Prasad and Mishra, 29 others including former IAS officers and animal husbandry officials are accused in the Dumka Treasury case.

Prasad had already been convicted in three fodder cases while Mishra was convicted in two fodder cases.

A special CBI court on January 24, sentenced Lalu Prasad and Jagannath Mishra to five years in jail in a fodder scam case related to fraudulent withdrawal of Rs 37.62 crore from the Chaibasa treasury.

On January 6, a special CBI court had sentenced Prasad to three-and-a-half years in jail and fined him Rs 10 lakh in a fodder scam case relating to fraudulent withdrawal of Rs 89.27 lakh from the Deoghar Treasury 21 years ago.

In 2013, Prasad was convicted in the first fodder scam case involving withdrawal of Rs 37.7 crore from the Chaibasa treasury.

Prasad has been lodged in the Birsa Munda jail at Ranchi since December 23 last year after being convicted in the second case pertaining to illegal withdrawal of money from the Deogarh treasury.

The over Rs 900-crore fodder scam cases relate to illegal withdrawal of money from government treasury in different districts in the animal husbandry department in undivided Bihar in 1990s when RJD was in power in the state.

Comments

Add new comment

About text formats
  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Nerwork
June 7,2020

New Delhi, Jun 7: Rain lashed some parts of the Delhi-NCR on Sunday morning.

The India Meteorological Department (IMD) has predicted partly cloudy sky with possibility of development of thunder lightning for three days from June 10 onwards with minimum and maximum temperature will hover around 29° Celcius and 42° Celcius respectively.

Strong surface winds during day time have been predicted for today by IMD.

Comments

Add new comment

About text formats
  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
April 30,2020

Bengaluru, Apr 30: Shares of Glenmark Pharmaceuticals Ltd rose almost 9% on Thursday after the Indian drugmaker got an approval to conduct clinical trials with antiviral drug favipiravir, seen as a potential treatment for COVID-19.

Favipiravir, manufactured under the brand name Avigan by a unit of Japan's Fujifilm Holdings Corp and approved for use as an anti-flu drug in the Asian island country in 2014, has been effective, with no obvious side-effects, in helping coronavirus patients recover, a Chinese official told reporters at a news conference last month.

"After having successfully developed the API and the formulations ... Glenmark is all geared to immediately begin clinical trials on favipiravir on COVID-19 patients in India," Sushrut Kulkarni, executive vice-president for Global R&D, Glenmark Pharmaceuticals, said in a statement. 

The Drug Controller General of India, the country's drug regulator, did not immediately respond to Reuters request for comment.

On Wednesday, another Indian pharmaceutical company, Strides Pharma Science Ltd, said it had developed and commercialized favipiravir antiviral tablets, and had applied to Indian drug authorities to start trials.

Shares of Mumbai-based Glenmark Pharmaceuticals, which rose as much as 8.9% to 359 rupees ($4.78), was trading up 5.9%, as of 0407 GMT.

Comments

Add new comment

About text formats
  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
July 12,2020

New Delhi, Jul 12: With the highest single-day spike of 28,637 new cases and 551 deaths being reported in the last 24 hours, India's COVID-19 count reached 8,49,553 on Sunday.

According to the Union Health and Family Welfare Ministry, this includes 2,92,258 active cases, and 5,34,621 cured and discharged or migrated patients. The toll due to the disease has reached 22,674 in the country.

Maharashtra with 2,46,600 cases continues to be the worst affected state by COVID-19 in the country. The state has 99,499 active cases while 1,36,985 patients have been cured and discharged so far. The death toll due to the disease now stands at 10,116.

Tamil Nadu with 1,34,226 cases, including 46,413 active ones, is the next worst affected in the country. While the number of cured and discharged patients is at 85,915 in the state, the toll due to the disease is at 1,898.

The national capital has recorded 1,10,921 confirmed cases so far. However, the number of active cases in Delhi is at 19,895 and 87,692 patients have been cured and discharged so far. With 3,334 deaths being reported due to COVID-19 in the city. 

Comments

Add new comment

About text formats
  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.